1223748-27-3

Usage

Uses

Used in Scientific Research:
N-ethyl-N-methyl-3-(pyrrolidin-3-yl)benzamide hydrochloride is used as a research tool for studying the role of α7 nicotinic acetylcholine receptors in neurotransmission and behavior. It aids in understanding the receptor's function and its potential involvement in various neurological processes.
Used in Pharmaceutical Development:
In the pharmaceutical industry, N-ethyl-N-methyl-3-(pyrrolidin-3-yl)benzamide hydrochloride is used as a lead compound in the development of drugs targeting neurological disorders and cognitive deficits. Its agonistic effect on the α7 nicotinic acetylcholine receptor suggests its potential in treating conditions related to cognitive impairment and neurodegenerative diseases.
Used in Neurological Disorder Treatment:
N-ethyl-N-methyl-3-(pyrrolidin-3-yl)benzamide hydrochloride is being investigated for its therapeutic potential in the treatment of neurological disorders. Its ability to modulate neurotransmission through the α7 nicotinic acetylcholine receptor may offer benefits in managing symptoms and potentially slowing disease progression in conditions such as Alzheimer's disease, schizophrenia, and other cognitive impairments.
Used in Cognitive Deficit Management:
N-ethyl-N-methyl-3-(pyrrolidin-3-yl)benzamide hydrochloride is also considered for use in managing cognitive deficits, where the enhancement of α7 nicotinic acetylcholine receptor activity may improve cognitive function and memory. Its application in this area is still under investigation, but the preliminary findings suggest its potential as a cognitive enhancer.